[1. Bai L., Zhu W.G.: p53: Structure, functions and therapeutic applications, J. Cancer. Mol., 2(4): 141-153, 2006.]Search in Google Scholar
[2. Blons H., Laurent-Puif P.: TP53 and head and neck neoplasm, Hum. Mutat., 20: 252-257, 2003.]Search in Google Scholar
[3. Costello J.F., Plass C.: Methylation matters, J. Med. Genet., 38: 285-303, 2001.]Search in Google Scholar
[4. Hsieh Y.Y., Wang J.P., Lin C.S.: Four novel single nucleotide polymorphism within the promoter region of p53 gene and their associations with uterine leiomyoma, Mol. Reprod. Dev., 74:815-820, 2007.]Search in Google Scholar
[5. Lane D.P.: Cancer. P53 guardian of genome, Nature, 358: 15-16, 1992.]Search in Google Scholar
[6. Lis P., Niczyj-Raucy M., Lis M.: The molecular basis of cancer and genetic methods of its diagnosis, Nat. J. (Opole), 44: 92-119, 2011.]Search in Google Scholar
[7. Nylander D.M, Dabelsteen E., Hall P.A.: The p53 molecule and its prognostic role in squamous cel carcinomas of the head and neck, J. Oral. Pathol. Med., 29 (9): 413-425, 2000.]Search in Google Scholar
[8. Rusin P., Markiewicz L., Majsterek I.: Genetic predeterminations of head and neck cancer, Post. Hig. Dos., 62: 490-501, 2008.]Search in Google Scholar
[9. Sznarkowska A., Olszewski R., Zawacka-Pankau J.: Farmakologiczna aktywacja supresora nowotworu, natywnego białka p53 jako obiecująca strategia zwalczania nowotworów, Post. Hig. Med. Dos., 64: 396-407, 2010.]Search in Google Scholar
[10. Wawryk-Gawda E., Chylińska-Wrzos P., Lis-Sochocka M. Chłapek K., Bulak K., Jędrych M., Jodłowska-Jędrych B.: P53protein in proliferation, repair and apoptosis of cells, Protoplasma, 251 (3): 525-533, 2014.10.1007/s00709-013-0548-1399783024043441]Search in Google Scholar
[11. Wojtasiński Z.: Ponad 14 mln nowych zachorowań na nowotwory na świecie, http://naukawpolsce.pap.pl/aktualnosci/news,402029,ponad-14-mln-nowych-zachorowan-na-nowotwory-na-swiecie.html.]Search in Google Scholar